CRBP vs T · $102.3M cap vs P/E 7.4, rev $63.06B
Corbus Pharmaceuticals Holding (CRBP) versus AT&T Inc. (T) — a side-by-side from cached financials, not a winner call.
Corbus Pharmaceuticals Holding (CRBP) is a biotechnology company listed on US.
AT&T Inc. (T) is a telecom services company listed on NYSE. It is led by John Stankey.
CRBP does not have a complete income-statement cache yet.
Latest reported T revenue for 2026-06-30 was $63.06B. Net income was $8.46B. T currently screens at market cap $155.92B and trailing P/E 7.4.
CRBP currently screens at market cap $102.3M. T currently screens at market cap $155.92B and trailing P/E 7.4.
Not investment advice. Open the CRBP and T stock pages for the full models.
Not investment advice.